Klaria Competitors and Similar CompaniesClear all
Exelixis's competitors and similar companies include Halozyme Therapeutics.
 Halozyme Therapeutics Halozyme Therapeutics is a biotechnology company focused on developing and commercializing cancer therapies that target the tumor microenvironment. | ||
Founding Date | Founding Date 1994 | Founding Date 1998 |
Type | Type Public | Type Public |
Tags | ||
Locations | Locations Alameda, US HQ | Locations San Diego, US HQ |
Employees | Employees 1,14712% decrease | Employees 373157% increase |
Valuation ($) | Valuation ($) 8.2 b | Valuation ($) 6.4 b |
Financial | ||
Revenue (est.) | Revenue (est.) $2.3b (FY, 2025) | Revenue (est.) $1.4b (FY, 2025) |
Cost of goods | Cost of goods $83.7m (FY, 2025) | Cost of goods $228.8m (FY, 2025) |
Gross profit | Gross profit $2.2b (FY, 2025) | Gross profit $1.2b (FY, 2025) |
Net income | Net income $782.6m (FY, 2025) | Net income $316.9m (FY, 2025) |
For sources of this data, please see the company profile
View Company Profiles
Halozyme Therapeutics
HQ
San Diego, US
Employees
373
Halozyme Therapeutics is a biotechnology company focused on developing and commercializing cancer therapies that target the tumor microenvironment.
View company